您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Antiarrhythic Drugs Report

健康网讯：

Market Report on Antiarrhythic Drugs in China

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$2,700 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com


1 Categories of antiarrhythic drugs and epidemiology
2 Market scale and growth trend
  2.1 Theoretical market scale
  2.2 Growth trend in the past few years
  2.3 Top 10 breeds ranked by sales value
  2.4 Comparison of domestic and import brand
  2.5 Analysis about DDDs and daily cost of drug
3 Market analysis of 4 categories drugs
  3.1 Natrium Ion Channel Blocker 
  3.2 β-receptor blocker
  3.3 Action potential duration prolongation agent
  3.4 Calcium Ion Channel Blocker
4 Market analysis of key breeds
  4.1 Natrium Ion Channel Blocker
     Ⅰa class: Quinidine, Procainamide, Acecainide, Disopyramide, etc.
     Ⅰb class: lidocaine, Phenytoin, Mexiletine, Aprindine, Tocainide,
 Moracizine, etc
     Ⅰc class: Encainide, Flecainide, Propafenone, etc
  4.2 β-receptor blocker
      Propranolol, Nadolol, Timolol, Metoprolol, Atenolol
  4.3  Action potential duration prolongation agent
     Amiodarone, britylium, Sotalol, Dofetilide, Ibutilide, Acecainide,
 Bunaftine, Cibenzoline 
  4.4 Calcium Ion Channel Blocker
     Verapamil, Tiapamil, Gallopamil, Diltiazem, Nifedipine
  4.5 Others